Lhasa Limited continues to expand in Latin America, welcoming members in Argentina, Colombia and Uruguay
- May 10, 2023
Lhasa Limited, a leading global supplier of knowledge-based software solutions and associated databases, continues its expansion in Latin America with new members joining in Argentina, Colombia and Uruguay.
Lhasa Limited introduce nitrosamine formation risk prediction technology to Mirabilis
- April 3, 2023
Lhasa Limited, a leading supplier of software solutions in the fields of toxicology, metabolism, degradation and purge chemistry, announce the latest release of Mirabilis – a risk assessment tool to assist with the management of your mutagenic impurities.
Vitic AI/PDE data release: Enhancing the safety of drug substances through data sharing
- March 2, 2023
Lhasa Limited is delighted to announce the release of new data to its Vitic Acceptable Intake (AI) and Permitted Daily Exposure (PDE) database users.
Vitic Nitrites – a new and evolved database that supports more scientifically driven nitrosamine impurity assessments
- February 1, 2023
Lhasa Limited is thrilled to announce the update of the Vitic Nitrites data sharing initiative, reflecting the expansion of the database to support more scientifically driven nitrosamine impurity assessments.
Vitic Excipients data release: sharing data on the effects of pharmaceutical excipients
- January 30, 2023
Lhasa Limited is pleased to announce the release of new data to its Vitic Excipients database users. The principal aim of this pre-competitive data sharing initiative is to facilitate the anonymous sharing of excipient and vehicle toxicity data, helping members to refine their experiments and minimise animal testing.
Lhasa Limited announce the launch of innovative solution to support ICH S1 carcinogenicity assessments
- December 21, 2022
Lhasa Limited is thrilled to announce the launch of Kaptis! Aligned with the recent finalisation of the ICH S1B(R1) guideline, Kaptis includes ICH S1 functionality.
Lhasa Limited unveil Mirabilis 4 – introducing a conditions-based approach for predicting reactivity, solubility and volatility
- December 15, 2022
Lhasa Limited is thrilled to unveil the release of Mirabilis version 4, our software tool for improving the evaluation of carry-over risk for potentially mutagenic impurities in drug substance synthesis.
Lhasa Limited releases new data to Aromatic Amines database users
- December 15, 2022
Lhasa Limited is delighted to announce the release of new data to its Vitic Aromatic Amines database users. The Aromatic Amines data sharing initiative is a collaboration of pharmaceutical organisations sharing data from Ames mutagenicity assays for primary aromatic amines.
Second release of the complex nitrosamines database announced to members
- December 6, 2022
Lhasa Limited is delighted to announce the second release of the Vitic complex nitrosamines database for 2022. Members of the consortium use mutagenicity studies from the shared database to further understand the risks associated with their potential nitrosamine impurities.
Lhasa Limited announces the anticipated release of Zeneth 9
- November 30, 2022
Lhasa Limited is thrilled to announce the anticipated release of Zeneth version 9, our in silico software solution for the identification of forced degradation pathways of organic compounds.